This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A prospective, randomized, open label blinded end ...
Clinical trial

A prospective, randomized, open label blinded end point (probe), cross-over study to compare the effects of telmisartan and losartan on metabolic profile of renal transplant patients

Read time: 1 mins
Last updated:31st Mar 2009
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest